 | • レポートコード：MRC2-11QY09481 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、152ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は鎌状赤血球症治療薬のグローバル市場について調査・分析したレポートです。種類別（ARQ-092、BIVV-003、CAL-H、CTX-001、DRX-194、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別鎌状赤血球症治療薬の競争状況、市場シェア ・世界の鎌状赤血球症治療薬市場：種類別市場規模 2015年-2020年（ARQ-092、BIVV-003、CAL-H、CTX-001、DRX-194、その他） ・世界の鎌状赤血球症治療薬市場：種類別市場規模予測 2021年-2026年（ARQ-092、BIVV-003、CAL-H、CTX-001、DRX-194、その他） ・世界の鎌状赤血球症治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の鎌状赤血球症治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の鎌状赤血球症治療薬市場分析：米国、カナダ ・ヨーロッパの鎌状赤血球症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの鎌状赤血球症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の鎌状赤血球症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの鎌状赤血球症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Acceleron Pharma Inc、Addmedica SAS、Angiocrine Bioscience Inc、Annexin Pharmaceuticals AB、ArQule Inc、Bio Products Laboratory Ltd、Bioverativ Inc、bluebird bio Inc、Bristol-Myers Squibb Co、Calimmune Inc、CRISPR Therapeutics、CSL Ltd、Daiichi Sankyo Co Ltd、Editas Medicine Inc、Errant Gene Therapeutics LLC、Gamida Cell Ltd、Genethon SA、Gilead Sciences Inc、Global Blood Therapeutics Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Sickle Cell Disease Drug Market
The global Sickle Cell Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Sickle Cell Disease Drug Scope and Market Size
Sickle Cell Disease Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sickle Cell Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Sickle Cell Disease Drug market is segmented into
ARQ-092
BIVV-003
CAL-H
CTX-001
DRX-194
Others
Segment by Application, the Sickle Cell Disease Drug market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Sickle Cell Disease Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Sickle Cell Disease Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Sickle Cell Disease Drug Market Share Analysis
Sickle Cell Disease Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Sickle Cell Disease Drug business, the date to enter into the Sickle Cell Disease Drug market, Sickle Cell Disease Drug product introduction, recent developments, etc.
The major vendors covered:
Acceleron Pharma Inc
Addmedica SAS
Angiocrine Bioscience Inc
Annexin Pharmaceuticals AB
ArQule Inc
Bio Products Laboratory Ltd
Bioverativ Inc
bluebird bio Inc
Bristol-Myers Squibb Co
Calimmune Inc
CRISPR Therapeutics
CSL Ltd
Daiichi Sankyo Co Ltd
Editas Medicine Inc
Errant Gene Therapeutics LLC
Gamida Cell Ltd
Genethon SA
Gilead Sciences Inc
Global Blood Therapeutics Inc
1 Study Coverage
1.1 Sickle Cell Disease Drug Product Introduction
1.2 Market Segments
1.3 Key Sickle Cell Disease Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Sickle Cell Disease Drug Market Size Growth Rate by Type
1.4.2 ARQ-092
1.4.3 BIVV-003
1.4.4 CAL-H
1.4.5 CTX-001
1.4.6 DRX-194
1.4.7 Others
1.5 Market by Application
1.5.1 Global Sickle Cell Disease Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Sickle Cell Disease Drug Market Size, Estimates and Forecasts
2.1.1 Global Sickle Cell Disease Drug Revenue 2015-2026
2.1.2 Global Sickle Cell Disease Drug Sales 2015-2026
2.2 Global Sickle Cell Disease Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Sickle Cell Disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Sickle Cell Disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Sickle Cell Disease Drug Competitor Landscape by Players
3.1 Sickle Cell Disease Drug Sales by Manufacturers
3.1.1 Sickle Cell Disease Drug Sales by Manufacturers (2015-2020)
3.1.2 Sickle Cell Disease Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Sickle Cell Disease Drug Revenue by Manufacturers
3.2.1 Sickle Cell Disease Drug Revenue by Manufacturers (2015-2020)
3.2.2 Sickle Cell Disease Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Sickle Cell Disease Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Sickle Cell Disease Drug Revenue in 2019
3.2.5 Global Sickle Cell Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Sickle Cell Disease Drug Price by Manufacturers
3.4 Sickle Cell Disease Drug Manufacturing Base Distribution, Product Types
3.4.1 Sickle Cell Disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Sickle Cell Disease Drug Product Type
3.4.3 Date of International Manufacturers Enter into Sickle Cell Disease Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Sickle Cell Disease Drug Market Size by Type (2015-2020)
4.1.1 Global Sickle Cell Disease Drug Sales by Type (2015-2020)
4.1.2 Global Sickle Cell Disease Drug Revenue by Type (2015-2020)
4.1.3 Sickle Cell Disease Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Sickle Cell Disease Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Sickle Cell Disease Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Sickle Cell Disease Drug Revenue Forecast by Type (2021-2026)
4.2.3 Sickle Cell Disease Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Sickle Cell Disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Sickle Cell Disease Drug Market Size by Application (2015-2020)
5.1.1 Global Sickle Cell Disease Drug Sales by Application (2015-2020)
5.1.2 Global Sickle Cell Disease Drug Revenue by Application (2015-2020)
5.1.3 Sickle Cell Disease Drug Price by Application (2015-2020)
5.2 Sickle Cell Disease Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Sickle Cell Disease Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Sickle Cell Disease Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Sickle Cell Disease Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Sickle Cell Disease Drug by Country
6.1.1 North America Sickle Cell Disease Drug Sales by Country
6.1.2 North America Sickle Cell Disease Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Sickle Cell Disease Drug Market Facts & Figures by Type
6.3 North America Sickle Cell Disease Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Sickle Cell Disease Drug by Country
7.1.1 Europe Sickle Cell Disease Drug Sales by Country
7.1.2 Europe Sickle Cell Disease Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Sickle Cell Disease Drug Market Facts & Figures by Type
7.3 Europe Sickle Cell Disease Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Sickle Cell Disease Drug by Region
8.1.1 Asia Pacific Sickle Cell Disease Drug Sales by Region
8.1.2 Asia Pacific Sickle Cell Disease Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Sickle Cell Disease Drug Market Facts & Figures by Type
8.3 Asia Pacific Sickle Cell Disease Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Sickle Cell Disease Drug by Country
9.1.1 Latin America Sickle Cell Disease Drug Sales by Country
9.1.2 Latin America Sickle Cell Disease Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Sickle Cell Disease Drug Market Facts & Figures by Type
9.3 Central & South America Sickle Cell Disease Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Sickle Cell Disease Drug by Country
10.1.1 Middle East and Africa Sickle Cell Disease Drug Sales by Country
10.1.2 Middle East and Africa Sickle Cell Disease Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Sickle Cell Disease Drug Market Facts & Figures by Type
10.3 Middle East and Africa Sickle Cell Disease Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Acceleron Pharma Inc
11.1.1 Acceleron Pharma Inc Corporation Information
11.1.2 Acceleron Pharma Inc Description and Business Overview
11.1.3 Acceleron Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Acceleron Pharma Inc Sickle Cell Disease Drug Products Offered
11.1.5 Acceleron Pharma Inc Related Developments
11.2 Addmedica SAS
11.2.1 Addmedica SAS Corporation Information
11.2.2 Addmedica SAS Description and Business Overview
11.2.3 Addmedica SAS Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Addmedica SAS Sickle Cell Disease Drug Products Offered
11.2.5 Addmedica SAS Related Developments
11.3 Angiocrine Bioscience Inc
11.3.1 Angiocrine Bioscience Inc Corporation Information
11.3.2 Angiocrine Bioscience Inc Description and Business Overview
11.3.3 Angiocrine Bioscience Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Angiocrine Bioscience Inc Sickle Cell Disease Drug Products Offered
11.3.5 Angiocrine Bioscience Inc Related Developments
11.4 Annexin Pharmaceuticals AB
11.4.1 Annexin Pharmaceuticals AB Corporation Information
11.4.2 Annexin Pharmaceuticals AB Description and Business Overview
11.4.3 Annexin Pharmaceuticals AB Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Products Offered
11.4.5 Annexin Pharmaceuticals AB Related Developments
11.5 ArQule Inc
11.5.1 ArQule Inc Corporation Information
11.5.2 ArQule Inc Description and Business Overview
11.5.3 ArQule Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 ArQule Inc Sickle Cell Disease Drug Products Offered
11.5.5 ArQule Inc Related Developments
11.6 Bio Products Laboratory Ltd
11.6.1 Bio Products Laboratory Ltd Corporation Information
11.6.2 Bio Products Laboratory Ltd Description and Business Overview
11.6.3 Bio Products Laboratory Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bio Products Laboratory Ltd Sickle Cell Disease Drug Products Offered
11.6.5 Bio Products Laboratory Ltd Related Developments
11.7 Bioverativ Inc
11.7.1 Bioverativ Inc Corporation Information
11.7.2 Bioverativ Inc Description and Business Overview
11.7.3 Bioverativ Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bioverativ Inc Sickle Cell Disease Drug Products Offered
11.7.5 Bioverativ Inc Related Developments
11.8 bluebird bio Inc
11.8.1 bluebird bio Inc Corporation Information
11.8.2 bluebird bio Inc Description and Business Overview
11.8.3 bluebird bio Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 bluebird bio Inc Sickle Cell Disease Drug Products Offered
11.8.5 bluebird bio Inc Related Developments
11.9 Bristol-Myers Squibb Co
11.9.1 Bristol-Myers Squibb Co Corporation Information
11.9.2 Bristol-Myers Squibb Co Description and Business Overview
11.9.3 Bristol-Myers Squibb Co Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bristol-Myers Squibb Co Sickle Cell Disease Drug Products Offered
11.9.5 Bristol-Myers Squibb Co Related Developments
11.10 Calimmune Inc
11.10.1 Calimmune Inc Corporation Information
11.10.2 Calimmune Inc Description and Business Overview
11.10.3 Calimmune Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Calimmune Inc Sickle Cell Disease Drug Products Offered
11.10.5 Calimmune Inc Related Developments
11.1 Acceleron Pharma Inc
11.1.1 Acceleron Pharma Inc Corporation Information
11.1.2 Acceleron Pharma Inc Description and Business Overview
11.1.3 Acceleron Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Acceleron Pharma Inc Sickle Cell Disease Drug Products Offered
11.1.5 Acceleron Pharma Inc Related Developments
11.12 CSL Ltd
11.12.1 CSL Ltd Corporation Information
11.12.2 CSL Ltd Description and Business Overview
11.12.3 CSL Ltd Sales, Revenue and Gross Margin (2015-2020)
11.12.4 CSL Ltd Products Offered
11.12.5 CSL Ltd Related Developments
11.13 Daiichi Sankyo Co Ltd
11.13.1 Daiichi Sankyo Co Ltd Corporation Information
11.13.2 Daiichi Sankyo Co Ltd Description and Business Overview
11.13.3 Daiichi Sankyo Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Daiichi Sankyo Co Ltd Products Offered
11.13.5 Daiichi Sankyo Co Ltd Related Developments
11.14 Editas Medicine Inc
11.14.1 Editas Medicine Inc Corporation Information
11.14.2 Editas Medicine Inc Description and Business Overview
11.14.3 Editas Medicine Inc Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Editas Medicine Inc Products Offered
11.14.5 Editas Medicine Inc Related Developments
11.15 Errant Gene Therapeutics LLC
11.15.1 Errant Gene Therapeutics LLC Corporation Information
11.15.2 Errant Gene Therapeutics LLC Description and Business Overview
11.15.3 Errant Gene Therapeutics LLC Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Errant Gene Therapeutics LLC Products Offered
11.15.5 Errant Gene Therapeutics LLC Related Developments
11.16 Gamida Cell Ltd
11.16.1 Gamida Cell Ltd Corporation Information
11.16.2 Gamida Cell Ltd Description and Business Overview
11.16.3 Gamida Cell Ltd Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Gamida Cell Ltd Products Offered
11.16.5 Gamida Cell Ltd Related Developments
11.17 Genethon SA
11.17.1 Genethon SA Corporation Information
11.17.2 Genethon SA Description and Business Overview
11.17.3 Genethon SA Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Genethon SA Products Offered
11.17.5 Genethon SA Related Developments
11.18 Gilead Sciences Inc
11.18.1 Gilead Sciences Inc Corporation Information
11.18.2 Gilead Sciences Inc Description and Business Overview
11.18.3 Gilead Sciences Inc Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Gilead Sciences Inc Products Offered
11.18.5 Gilead Sciences Inc Related Developments
11.19 Global Blood Therapeutics Inc
11.19.1 Global Blood Therapeutics Inc Corporation Information
11.19.2 Global Blood Therapeutics Inc Description and Business Overview
11.19.3 Global Blood Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Global Blood Therapeutics Inc Products Offered
11.19.5 Global Blood Therapeutics Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Sickle Cell Disease Drug Market Estimates and Projections by Region
12.1.1 Global Sickle Cell Disease Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Sickle Cell Disease Drug Revenue Forecast by Regions 2021-2026
12.2 North America Sickle Cell Disease Drug Market Size Forecast (2021-2026)
12.2.1 North America: Sickle Cell Disease Drug Sales Forecast (2021-2026)
12.2.2 North America: Sickle Cell Disease Drug Revenue Forecast (2021-2026)
12.2.3 North America: Sickle Cell Disease Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Sickle Cell Disease Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Sickle Cell Disease Drug Sales Forecast (2021-2026)
12.3.2 Europe: Sickle Cell Disease Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Sickle Cell Disease Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Sickle Cell Disease Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Sickle Cell Disease Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Sickle Cell Disease Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Sickle Cell Disease Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Sickle Cell Disease Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Sickle Cell Disease Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Sickle Cell Disease Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Sickle Cell Disease Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Sickle Cell Disease Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Sickle Cell Disease Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Sickle Cell Disease Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Sickle Cell Disease Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Sickle Cell Disease Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Sickle Cell Disease Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Sickle Cell Disease Drug Market Segments
Table 2. Ranking of Global Top Sickle Cell Disease Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Sickle Cell Disease Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of ARQ-092
Table 5. Major Manufacturers of BIVV-003
Table 6. Major Manufacturers of CAL-H
Table 7. Major Manufacturers of CTX-001
Table 8. Major Manufacturers of DRX-194
Table 9. Major Manufacturers of Others
Table 10. Global Sickle Cell Disease Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Sickle Cell Disease Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Sickle Cell Disease Drug Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Sickle Cell Disease Drug Sales Market Share by Regions (2015-2020)
Table 14. Global Sickle Cell Disease Drug Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Sickle Cell Disease Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Sickle Cell Disease Drug Sales Share by Manufacturers (2015-2020)
Table 17. Global Sickle Cell Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Sickle Cell Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell Disease Drug as of 2019)
Table 19. Sickle Cell Disease Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Sickle Cell Disease Drug Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Sickle Cell Disease Drug Price (2015-2020) (USD/Pcs)
Table 22. Sickle Cell Disease Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Sickle Cell Disease Drug Product Type
Table 24. Date of International Manufacturers Enter into Sickle Cell Disease Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Sickle Cell Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 27. Global Sickle Cell Disease Drug Sales Share by Type (2015-2020)
Table 28. Global Sickle Cell Disease Drug Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Sickle Cell Disease Drug Revenue Share by Type (2015-2020)
Table 30. Sickle Cell Disease Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Sickle Cell Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 32. Global Sickle Cell Disease Drug Sales Share by Application (2015-2020)
Table 33. North America Sickle Cell Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 34. North America Sickle Cell Disease Drug Sales Market Share by Country (2015-2020)
Table 35. North America Sickle Cell Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Sickle Cell Disease Drug Revenue Market Share by Country (2015-2020)
Table 37. North America Sickle Cell Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 38. North America Sickle Cell Disease Drug Sales Market Share by Type (2015-2020)
Table 39. North America Sickle Cell Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 40. North America Sickle Cell Disease Drug Sales Market Share by Application (2015-2020)
Table 41. Europe Sickle Cell Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Sickle Cell Disease Drug Sales Market Share by Country (2015-2020)
Table 43. Europe Sickle Cell Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Sickle Cell Disease Drug Revenue Market Share by Country (2015-2020)
Table 45. Europe Sickle Cell Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Sickle Cell Disease Drug Sales Market Share by Type (2015-2020)
Table 47. Europe Sickle Cell Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Sickle Cell Disease Drug Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Sickle Cell Disease Drug Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Sickle Cell Disease Drug Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Sickle Cell Disease Drug Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Sickle Cell Disease Drug Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Sickle Cell Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Sickle Cell Disease Drug Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Sickle Cell Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Sickle Cell Disease Drug Sales Market Share by Application (2015-2020)
Table 57. Latin America Sickle Cell Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Sickle Cell Disease Drug Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Sickle Cell Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Sickle Cell Disease Drug Revenue Market Share by Country (2015-2020)
Table 61. Latin America Sickle Cell Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Sickle Cell Disease Drug Sales Market Share by Type (2015-2020)
Table 63. Latin America Sickle Cell Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Sickle Cell Disease Drug Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Sickle Cell Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Sickle Cell Disease Drug Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Sickle Cell Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Sickle Cell Disease Drug Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Sickle Cell Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Sickle Cell Disease Drug Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Sickle Cell Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Sickle Cell Disease Drug Sales Market Share by Application (2015-2020)
Table 73. Acceleron Pharma Inc Corporation Information
Table 74. Acceleron Pharma Inc Description and Major Businesses
Table 75. Acceleron Pharma Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Acceleron Pharma Inc Product
Table 77. Acceleron Pharma Inc Recent Development
Table 78. Addmedica SAS Corporation Information
Table 79. Addmedica SAS Description and Major Businesses
Table 80. Addmedica SAS Sickle Cell Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Addmedica SAS Product
Table 82. Addmedica SAS Recent Development
Table 83. Angiocrine Bioscience Inc Corporation Information
Table 84. Angiocrine Bioscience Inc Description and Major Businesses
Table 85. Angiocrine Bioscience Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Angiocrine Bioscience Inc Product
Table 87. Angiocrine Bioscience Inc Recent Development
Table 88. Annexin Pharmaceuticals AB Corporation Information
Table 89. Annexin Pharmaceuticals AB Description and Major Businesses
Table 90. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Annexin Pharmaceuticals AB Product
Table 92. Annexin Pharmaceuticals AB Recent Development
Table 93. ArQule Inc Corporation Information
Table 94. ArQule Inc Description and Major Businesses
Table 95. ArQule Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. ArQule Inc Product
Table 97. ArQule Inc Recent Development
Table 98. Bio Products Laboratory Ltd Corporation Information
Table 99. Bio Products Laboratory Ltd Description and Major Businesses
Table 100. Bio Products Laboratory Ltd Sickle Cell Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Bio Products Laboratory Ltd Product
Table 102. Bio Products Laboratory Ltd Recent Development
Table 103. Bioverativ Inc Corporation Information
Table 104. Bioverativ Inc Description and Major Businesses
Table 105. Bioverativ Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Bioverativ Inc Product
Table 107. Bioverativ Inc Recent Development
Table 108. bluebird bio Inc Corporation Information
Table 109. bluebird bio Inc Description and Major Businesses
Table 110. bluebird bio Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. bluebird bio Inc Product
Table 112. bluebird bio Inc Recent Development
Table 113. Bristol-Myers Squibb Co Corporation Information
Table 114. Bristol-Myers Squibb Co Description and Major Businesses
Table 115. Bristol-Myers Squibb Co Sickle Cell Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Bristol-Myers Squibb Co Product
Table 117. Bristol-Myers Squibb Co Recent Development
Table 118. Calimmune Inc Corporation Information
Table 119. Calimmune Inc Description and Major Businesses
Table 120. Calimmune Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Calimmune Inc Product
Table 122. Calimmune Inc Recent Development
Table 123. CRISPR Therapeutics Corporation Information
Table 124. CRISPR Therapeutics Description and Major Businesses
Table 125. CRISPR Therapeutics Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. CRISPR Therapeutics Product
Table 127. CRISPR Therapeutics Recent Development
Table 128. CSL Ltd Corporation Information
Table 129. CSL Ltd Description and Major Businesses
Table 130. CSL Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. CSL Ltd Product
Table 132. CSL Ltd Recent Development
Table 133. Daiichi Sankyo Co Ltd Corporation Information
Table 134. Daiichi Sankyo Co Ltd Description and Major Businesses
Table 135. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 136. Daiichi Sankyo Co Ltd Product
Table 137. Daiichi Sankyo Co Ltd Recent Development
Table 138. Editas Medicine Inc Corporation Information
Table 139. Editas Medicine Inc Description and Major Businesses
Table 140. Editas Medicine Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 141. Editas Medicine Inc Product
Table 142. Editas Medicine Inc Recent Development
Table 143. Errant Gene Therapeutics LLC Corporation Information
Table 144. Errant Gene Therapeutics LLC Description and Major Businesses
Table 145. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 146. Errant Gene Therapeutics LLC Product
Table 147. Errant Gene Therapeutics LLC Recent Development
Table 148. Gamida Cell Ltd Corporation Information
Table 149. Gamida Cell Ltd Description and Major Businesses
Table 150. Gamida Cell Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 151. Gamida Cell Ltd Product
Table 152. Gamida Cell Ltd Recent Development
Table 153. Genethon SA Corporation Information
Table 154. Genethon SA Description and Major Businesses
Table 155. Genethon SA Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 156. Genethon SA Product
Table 157. Genethon SA Recent Development
Table 158. Gilead Sciences Inc Corporation Information
Table 159. Gilead Sciences Inc Description and Major Businesses
Table 160. Gilead Sciences Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 161. Gilead Sciences Inc Product
Table 162. Gilead Sciences Inc Recent Development
Table 163. Global Blood Therapeutics Inc Corporation Information
Table 164. Global Blood Therapeutics Inc Description and Major Businesses
Table 165. Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 166. Global Blood Therapeutics Inc Product
Table 167. Global Blood Therapeutics Inc Recent Development
Table 168. Global Sickle Cell Disease Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 169. Global Sickle Cell Disease Drug Sales Market Share Forecast by Regions (2021-2026)
Table 170. Global Sickle Cell Disease Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 171. Global Sickle Cell Disease Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 172. North America: Sickle Cell Disease Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 173. North America: Sickle Cell Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 174. Europe: Sickle Cell Disease Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 175. Europe: Sickle Cell Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 176. Asia Pacific: Sickle Cell Disease Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 177. Asia Pacific: Sickle Cell Disease Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 178. Latin America: Sickle Cell Disease Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 179. Latin America: Sickle Cell Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 180. Middle East and Africa: Sickle Cell Disease Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 181. Middle East and Africa: Sickle Cell Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 182. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 183. Key Challenges
Table 184. Market Risks
Table 185. Main Points Interviewed from Key Sickle Cell Disease Drug Players
Table 186. Sickle Cell Disease Drug Customers List
Table 187. Sickle Cell Disease Drug Distributors List
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Sickle Cell Disease Drug Product Picture
Figure 2. Global Sickle Cell Disease Drug Sales Market Share by Type in 2020 & 2026
Figure 3. ARQ-092 Product Picture
Figure 4. BIVV-003 Product Picture
Figure 5. CAL-H Product Picture
Figure 6. CTX-001 Product Picture
Figure 7. DRX-194 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Sickle Cell Disease Drug Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Sickle Cell Disease Drug Report Years Considered
Figure 14. Global Sickle Cell Disease Drug Market Size 2015-2026 (US$ Million)
Figure 15. Global Sickle Cell Disease Drug Sales 2015-2026 (K Pcs)
Figure 16. Global Sickle Cell Disease Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Sickle Cell Disease Drug Sales Market Share by Region (2015-2020)
Figure 18. Global Sickle Cell Disease Drug Sales Market Share by Region in 2019
Figure 19. Global Sickle Cell Disease Drug Revenue Market Share by Region (2015-2020)
Figure 20. Global Sickle Cell Disease Drug Revenue Market Share by Region in 2019
Figure 21. Global Sickle Cell Disease Drug Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Sickle Cell Disease Drug Revenue in 2019
Figure 23. Sickle Cell Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Sickle Cell Disease Drug Sales Market Share by Type (2015-2020)
Figure 25. Global Sickle Cell Disease Drug Sales Market Share by Type in 2019
Figure 26. Global Sickle Cell Disease Drug Revenue Market Share by Type (2015-2020)
Figure 27. Global Sickle Cell Disease Drug Revenue Market Share by Type in 2019
Figure 28. Global Sickle Cell Disease Drug Market Share by Price Range (2015-2020)
Figure 29. Global Sickle Cell Disease Drug Sales Market Share by Application (2015-2020)
Figure 30. Global Sickle Cell Disease Drug Sales Market Share by Application in 2019
Figure 31. Global Sickle Cell Disease Drug Revenue Market Share by Application (2015-2020)
Figure 32. Global Sickle Cell Disease Drug Revenue Market Share by Application in 2019
Figure 33. North America Sickle Cell Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Sickle Cell Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Sickle Cell Disease Drug Sales Market Share by Country in 2019
Figure 36. North America Sickle Cell Disease Drug Revenue Market Share by Country in 2019
Figure 37. U.S. Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Sickle Cell Disease Drug Market Share by Type in 2019
Figure 42. North America Sickle Cell Disease Drug Market Share by Application in 2019
Figure 43. Europe Sickle Cell Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Sickle Cell Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Sickle Cell Disease Drug Sales Market Share by Country in 2019
Figure 46. Europe Sickle Cell Disease Drug Revenue Market Share by Country in 2019
Figure 47. Germany Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Sickle Cell Disease Drug Market Share by Type in 2019
Figure 58. Europe Sickle Cell Disease Drug Market Share by Application in 2019
Figure 59. Asia Pacific Sickle Cell Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Sickle Cell Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Sickle Cell Disease Drug Sales Market Share by Region in 2019
Figure 62. Asia Pacific Sickle Cell Disease Drug Revenue Market Share by Region in 2019
Figure 63. China Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Sickle Cell Disease Drug Market Share by Type in 2019
Figure 86. Asia Pacific Sickle Cell Disease Drug Market Share by Application in 2019
Figure 87. Latin America Sickle Cell Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Sickle Cell Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Sickle Cell Disease Drug Sales Market Share by Country in 2019
Figure 90. Latin America Sickle Cell Disease Drug Revenue Market Share by Country in 2019
Figure 91. Mexico Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Sickle Cell Disease Drug Market Share by Type in 2019
Figure 98. Latin America Sickle Cell Disease Drug Market Share by Application in 2019
Figure 99. Middle East and Africa Sickle Cell Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Sickle Cell Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Sickle Cell Disease Drug Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Sickle Cell Disease Drug Revenue Market Share by Country in 2019
Figure 103. Turkey Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Sickle Cell Disease Drug Market Share by Type in 2019
Figure 110. Middle East and Africa Sickle Cell Disease Drug Market Share by Application in 2019
Figure 111. North America Sickle Cell Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Sickle Cell Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Sickle Cell Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Sickle Cell Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Sickle Cell Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Sickle Cell Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Sickle Cell Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Sickle Cell Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Sickle Cell Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Sickle Cell Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
血管閉塞症・鎌状赤血球症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market The global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-20…- 鎌状赤血球の世界市場（～2026年） The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some fac…
- 鎌状赤血球貧血治療薬の世界市場（～2026年） Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…
- ベーチェット病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Behcet Disease Drug Market The global Behcet Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Behcet Disease Drug Scope and Market Size Behcet Disease Drug market is seg…
- クローン病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Crohn’s Disease Drug Market The global Crohn’s Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Crohn’s Disease Drug Scope and Market Size Crohn’s Disease Drug market is…